CCIA
ELV icon

Campbell & Co Investment Adviser’s Elevance Health ELV Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.53M Buy
9,122
+2,275
+33% +$844K 0.18% 152
2026
Q1 		$2M Buy
+6,847
New +$2.25M 0.11% 274
2025
Q1 		– Sell
-22,085
Closed -$8.15M – 1105
2024
Q4 		$8.15M Buy
22,085
+11,806
+115% +$4.94M 0.63% 7
2024
Q3 		$5.35M Buy
+10,279
New +$5.49M 0.4% 31
2024
Q2 		– Sell
-1,778
Closed -$922K – 1120
2024
Q1 		$922K Buy
+1,778
New +$884K 0.08% 434
2023
Q4 		– Sell
-5,755
Closed -$2.51M – 1159
2023
Q3 		$2.51M Buy
5,755
+4,280
+290% +$1.94M 0.3% 56
2023
Q2 		$655K Buy
1,475
+777
+111% +$358K 0.12% 303
2023
Q1 		$321K Buy
+698
New +$332K 0.06% 582
2022
Q4 		– Sell
-1,527
Closed -$694K – 821
2022
Q3 		$694K Buy
+1,527
New +$731K 0.16% 213
2022
Q2 		– Sell
-1,392
Closed -$684K – 736
2022
Q1 		$684K Buy
+1,392
New +$636K 0.18% 171
2020
Q3 		– Sell
-1,189
Closed -$313K – 405
2020
Q2 		$313K Buy
+1,189
New +$317K 0.4% 96
2020
Q1 		– Sell
-4,924
Closed -$1.49M – 173
2019
Q4 		$1.49M Buy
4,924
+3,023
+159% +$832K 0.46% 22
2019
Q3 		$456K Buy
+1,901
New +$521K 0.17% 212
2018
Q3 		– Sell
-1,548
Closed -$368K – 431
2018
Q2 		$368K Buy
1,548
+300
+24% +$69.5K 0.28% 128
2018
Q1 		$274K Buy
+1,248
New +$293K 0.23% 198
2017
Q4 		– Sell
-1,382
Closed -$262K – 427
2017
Q3 		$262K Sell
1,382
-537
-28% -$102K 0.21% 194
2017
Q2 		$361K Buy
+1,919
New +$345K 0.34% 96
2015
Q3 		– Sell
-2,794
Closed -$459K – 342
2015
Q2 		$459K Buy
+2,794
New +$446K 0.39% 86

Other funds holding ELV

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Campbell & Co Investment Adviser's ELV Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Elevance Health (ELV) stake by 33% in Q2 2026, buying an estimated $844K and bringing the position to 9,122 shares worth $3.53M. The position accounts for 0.18% of the portfolio, ranked #152.

Campbell & Co Investment Adviser first reported a position in ELV in Q2 2015 and has held it in 18 quarters since. The position peaked at $8.15M in Q4 2024. 733 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Campbell & Co Investment Adviser held 9,122 shares of Elevance Health worth $3.53M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 2,275 Elevance Health shares in Q2 2026, an estimated $844K.
  • Elevance Health made up 0.18% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #152 holding.
  • Campbell & Co Investment Adviser first reported a position in Elevance Health in Q2 2015 and has held it in 18 quarters since.
  • Campbell & Co Investment Adviser's Elevance Health position peaked at $8.15M in Q4 2024.
  • 733 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.